Metabical: Pricing, Packaging, and Demand Forecasting for a New Weight-Loss Drug

In 2008, a marketing and positioning strategy was needed for Cambridge Sciences Pharmaceutical’s (CSP) new weight loss drug called Metabical. Metabical was touted as being a revolutionary weight loss drug with fewer negative side effects than the usual medicinal weight loss remedies.

Dosages of the drug vary from one extreme to another based upon the patients needs.

5. Predict: How often do you think the patient should take a pill? Every 2 to 4 hours

Ensures all the pills are separated into the correct times as well as days. And

Since Metabical is a prescription drug for weight loss which can only be bought via a prescription, the overweight patients are not the only decision makers involved. The health care providers are also decision makers in this process for they are the ones who prescribe the drug.

Dostinex medication dose depends on a number of factors, for example, the condition being treated and how a patient reacts to the initial dose of the medication. When used to prevent normal lactation, the dose given is 1 mg taken on the first day after delivery. As for the prolactin disorder, the starting dose is 0.5 mg weekly. If need be, increments may be done by 0.5 mg weekly, till a maximum dose of 2 mg is attained and the dosage should be increased after every four

Please be advise to consume only one pill every six hours, two times a day. High-risk of multiple pregnancy will occur, if consuming more than the recommended

b.ii. The dosage will depend on the age, weight, and other health issues of the person.

The problematic issue for Bristol-Myers was to position its new aspirin drug to the potential customers and decide a good price which can not only make it acceptable by the customers, but also give a fair profit to the company. In other words, the company had to formulate an effective marketing and promotional strategy for its new drug, Datril. The company was not merely willing to establish its new brand in the analgesic market; the main issue was to establish this new brand in the presence of a strong competitor, Tylenol.

Patients randomized to Rituximab will receive 400 mg intravenously (IV) every 3 weeks up to 12 months. Patients randomized to standard of care for chemotherapy will receive treatment per the Physician’s choice and recommended dosage. All patients will be followed for up to 24 months after last dose of study medications or until death. Overall response rate (ORR), progression-free survival (PFS), overall survival (OS) and clinical benefit will be determined.

For example, Vedula (2012) notes that FDA guidelines state pharmaceutical companies can use peer-reviewed articles to publicize evidence of a drug’s effectiveness for off-label uses, as long as a number of conditions are met—perhaps the most essential of which is that “the information disseminated must not be false or misleading.” However, Vedula continues, there is no unyielding regulation that all research findings have to be published. Therefore, a company can still choose to selectively disseminate favorable findings. His article concludes that there is now a copious amount of evidence that suggests selective reporting of study results, based on the strength and direction of findings, is performed extensively by the pharmaceutical industry.

There are several considerations to take into account when deciding on a package account. Printup concluded that Metabical was most effective for 12 weeks. This meant consumers taking Metabical would be most satisfied with their results if they were consistently committed to taking the pill on a daily basis. If the individual missed a day, he or she would not yield long-lasting results and most likely regard the drug as a failure. Printup also had to consider that there was enough for individuals to take a pill a day without forgetting or skipping a day. In order to do so, Printup believed designing a package similar to birth control pills so consumers

budget for production costs and expenses, and for changing the curent portion packs. There are two

2000mg/day. If doses >2000mg/day are required, give in 3 divided doses (not to exceed 2500mg/day)

What are the factors deciding packaging count decisions? How many tablets in a packet of drug? What should be the pricing strategy?